Decoding dysregulated genes, molecular pathways and microRNAs involved in cervical cancer

被引:1
|
作者
Khokhar, Manoj [1 ]
Kartha, Purnima [2 ]
Hassan, Sana [3 ]
Pandey, Rajan Kumar [4 ]
机构
[1] All India Inst Med Sci Jodhpur, Dept Biochem, Jodhpur, Rajasthan, India
[2] Rajiv Gandhi Ctr Biotechnol, Thiruvananthapuram, Kerala, India
[3] Manipal Acad Higher Educ, Dept Life Sci, Dubai, U Arab Emirates
[4] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden
来源
JOURNAL OF GENE MEDICINE | 2024年 / 26卷 / 07期
关键词
CCNA2; CCND1; cell cycle dysregulation; cervical cancer; gene expression; HPV; human papillomavirus; microRNA; SPP1; EXPRESSION; TRANSCRIPTION; SP1; HPV; METASTASIS; SIGNATURES; INFECTION; CAPACITY; PROMOTES; GROWTH;
D O I
10.1002/jgm.3713
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
BackgroundThe present study aimed to identify dysregulated genes, molecular pathways, and regulatory mechanisms in human papillomavirus (HPV)-associated cervical cancers. We have investigated the disease-associated genes along with the Gene Ontology, survival prognosis, transcription factors and the microRNA (miRNA) that are involved in cervical carcinogenesis, enabling a deeper comprehension of cervical cancer linked to HPV.MethodsWe used 10 publicly accessible Gene Expression Omnibus (GEO) datasets to examine the patterns of gene expression in cervical cancer. Differentially expressed genes (DEGs), which showed a clear distinction between cervical cancer and healthy tissue samples, were analyzed using the GEO2R tool. Additional bioinformatic techniques were used to carry out pathway analysis and functional enrichment, as well as to analyze the connection between altered gene expression and HPV infection.ResultsIn total, 48 DEGs were identified to be differentially expressed in cervical cancer tissues in comparison to healthy tissues. Among DEGs, CCND1, CCNA2 and SPP1 were the key dysregulated genes involved in HPV-associated cervical cancer. The five common miRNAs that were identified against these genes are miR-7-5p, miR-16-5p, miR-124-3p, miR-10b-5p and miR-27a-3p. The hub-DEGs targeted by miRNA hsa-miR-27a-3p are controlled by the common transcription factor SP1.ConclusionsThe present study has identified DEGs involved in HPV-associated cervical cancer progression and the various molecular pathways and transcription factors regulating them. These findings have led to a better understanding of cervical cancer resulting in the development and identification of possible therapeutic and intervention targets, respectively. image This study identifies dysregulated genes, molecular pathways, and regulatory mechanisms in human papillomavirus (HPV)-associated cervical cancers. Using 10 Gene Expression Omnibus (GEO) datasets, 48 differentially expressed genes (DEGs) were found in cervical cancer tissues. Key genes include CCND1, CCNA2, and SPP1, while key miRNAs are miR-7-5p, miR-16-5p, miR-124-3p, miR-10b-5p, and miR-27a-3p. The transcription factor SP1 regulates these DEGs. These findings enhance understanding of cervical cancer and suggest potential therapeutic targets.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] Bioinformatics Analysis of Key Genes and Pathways of Cervical Cancer
    Chen, Huan
    Wang, Xi
    Jia, Huanhuan
    Tao, Yin
    Zhou, Hong
    Wang, Mingyuan
    Wang, Xin
    Fang, Xiaoling
    ONCOTARGETS AND THERAPY, 2020, 13 : 13275 - 13283
  • [22] Current perspectives on the dysregulated microRNAs in gastric cancer
    Azarbarzin, Shirin
    Safaralizadeh, Reza
    Khojasteh, Mahdi Banan
    Baghbanzadeh, Amir
    Baradaran, Behzad
    MOLECULAR BIOLOGY REPORTS, 2020, 47 (09) : 7253 - 7264
  • [23] Current perspectives on the dysregulated microRNAs in gastric cancer
    Shirin Azarbarzin
    Reza Safaralizadeh
    Mahdi Banan Khojasteh
    Amir Baghbanzadeh
    Behzad Baradaran
    Molecular Biology Reports, 2020, 47 : 7253 - 7264
  • [24] Dysregulated microRNAs in type 2 diabetes and breast cancer: Potential associated molecular mechanisms
    Improta-Caria, Alex Cleber
    Ferrari, Filipe
    Gomes, Joao Lucas Penteado
    Villalta, Paloma Brasilio
    Soci, Ursula Paula Reno
    Stein, Ricardo
    Oliveira, Edilamar M.
    WORLD JOURNAL OF DIABETES, 2024, 15 (06)
  • [25] Interleukin-22 and associated genes are targets of microRNAs dysregulated
    Tarn, Jessica R.
    Nordmark, Gunnel
    Gillespie, Colin
    Al-Ali, Shereen
    James, Katherine
    Mitchell, Sheryl
    Bowman, Simon
    Griffiths, Bridget
    Johnsen, Svein Joar Auglaend
    Norheim, Katrine
    Backlin, Carin
    Ronnblom, Lars
    Eloranta, Maija-Leena
    Omdal, Roald
    Young, David Alan
    Ng, Wan-Fai
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (03) : S327 - S327
  • [26] Epigenetic silencing of genes involved in signaling pathways in gastric cancer
    Toyota, Minoru
    Suzuki, Hiromu
    Nojima, Masanori
    Yasui, Hiroshi
    Shinomura, Yasuhisa
    Imai, Kohzoh
    TUMOR BIOLOGY, 2007, 28 : 23 - 23
  • [27] DYSREGULATED GENES INVOLVED IN IMPLANTATION FAILURE IN WOMEN WITH ENDOMETRIOSIS
    Nayar, K. D.
    Saxena, M.
    Singh, M.
    Ahuja, R.
    Gupta, M.
    Kant, G.
    Sharma, N.
    Nayar, D.
    FERTILITY AND STERILITY, 2017, 108 (03) : E200 - E201
  • [28] Exploring Dysregulated Signaling Pathways in Cancer
    Nisar, Sabah
    Hashem, Sheema
    Macha, Muzafar A.
    Yadav, Santosh K.
    Muralitharan, Sankavi
    Azeez, Lubna
    Sageena, Geetanjali
    Al-Naemi, Hamda
    Haris, Mohammad
    Bhat, Ajaz A.
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (04) : 429 - 445
  • [29] Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer
    Ebadfardzadeh, Johann
    Kazemi, Mandana
    Aghazadeh, Ali
    Rezaei, Monireh
    Shirvaliloo, Milad
    Sheervalilou, Roghayeh
    MEDICAL ONCOLOGY, 2021, 38 (09)
  • [30] In silico analysis of genes and molecular pathways involved in the pathogenesis of follicular lymphoma
    Abdulwahid, Al-Hasnawi Rasool Riyadh
    Mahdi, Mohammed H.
    Amiri, Bahareh Shateri
    Koosehlar, Eman
    Kazemi, Niloufar
    Ghiasi, Fatemeh
    Ghobadi, Shaghayegh
    Rezaeeyan, Hadi
    IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2024, 14 (03) : 205 - 216